NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on Thursday, May 12, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay Pharmaceuticals Inc (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on Thursday, May 12, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
| Date/Time: |
| Thursday, May 12, 4:30 p.m. ET / 1:30 p.m. PT |
|
|
|
|
| Pre-Registration: |
| Participants can pre-register for the conference call here: |
|
|
| Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. |
|
|
|
|
| Dial In: |
| Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call: |
|
|
| 866-777-2509 from within the U.S. |
|
|
| 412-317-5413 from outside the U.S. |
The live webcast of the conference call also will be available at http://novabay.com/investors/events. A replay of the call will be available beginning two hours after its completion through June 2, 2022 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 9711049. The webcast will also be archived at http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray in the eyecare market. In November 2021, NovaBay acquired DERMAdoctor, LLC, a company offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.
Socialize and Stay Informed on NovaBay’s Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website
Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com
DERMAdoctor Purchasing Information
For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220505005162/en/
Contacts
NovaBay Contact
Justin Hall
Chief Executive Officer and General Counsel
510-899-8800
jhall@novabay.com
Investor Contact
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com
Source: NovaBay Pharmaceuticals, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20220505005162/en
